Comparability of differential proteomics data generated from paired archival fresh-frozen and formalin-fixed samples by GeLC-MS/MS and spectral counting

Journal of Proteomics

Volumn 77, Issue , 2012, Pages 561-576

  Tanca, Alessandro ^a   Pagnozzi, Daniela ^a   Burrai, Giovanni P ^b   Polinas, Marta ^b   Uzzau, Sergio ^a,b   Antuofermo, Elisabetta ^b   Addis, Maria Filippa ^a  

^a Porto Conte Ricerche Srl   (Italy)

^b UNIVERSITY OF SASSARI   (Italy)

Author keywords

Archival samples; Biorepository; FFPE; GeLC MS MS; Spectral counting

Indexed keywords

FORMALDEHYDE; PARAFFIN; PROTEOME;

AMINO ACID SEQUENCE; ANALYSIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BREAST CARCINOMA; CELLULAR DISTRIBUTION; COMPARATIVE STUDY; CONTROLLED STUDY; DOG; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; NONHUMAN; PHYSICAL CHEMISTRY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN MODIFICATION; PROTEOMICS; SIGNAL TRANSDUCTION; SPECTRAL COUNTING;

ANIMALS; DOGS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; FEMALE; MAMMARY NEOPLASMS, ANIMAL; MASS SPECTROMETRY; NEOPLASM PROTEINS; PROTEOMICS;

EID: 84870393717     PISSN: 18743919     EISSN: 18767737     Source Type: Journal    
DOI: 10.1016/j.jprot.2012.09.033     Document Type: Article

References (117)

1. Guo T., Lee C.S., Wang W., DeVoe D.L., Balgley B.M. Capillary separations enabling tissue proteomics-based biomarker discovery. Electrophoresis 2006, 27:3523-3532.
2. Rifai N., Gillette M.A., Carr S.A. Protein biomarker discovery and validation: the long and uncertain path to clinical utility. Nat Biotechnol 2006, 24:971-983.
3. Fang X., Balgley B.M., Wang W., Park D.M., Lee C.S. Comparison of multidimensional shotgun technologies targeting tissue proteomics. Electrophoresis 2009, 30:4063-4070.
4. Lehmann U., Bock O., Glockner S., Kreipe H. Quantitative molecular analysis of laser-microdissected paraffin-embedded human tissues. Pathobiol 2000, 68:202-208.
5. Paik S., Kim C.Y., Song Y.K., Kim W.S. Technology insight: application of molecular techniques to formalin-fixed paraffin-embedded tissues from breast cancer. Nat Clin Pract Oncol 2005, 2:246-254.
6. Klopfleisch R., Weiss A.T., Gruber A.D. Excavation of a buried treasure-DNA, mRNA, miRNA and protein analysis in formalin fixed, paraffin embedded tissues. Histol Histopathol 2011, 26:797-810.
7. Ralton L.D., Murray G.I. The use of formalin fixed wax embedded tissue for proteomic analysis. J Clin Pathol 2011, 64:297-302.
8. Metz B., Kersten G.F.A., Hoogerhout P., Brugghe H.F., Timmermans H.A.M., de Jong A., et al. Identification of formaldehyde-induced modifications in proteins. J Biol Chem 2004, 279:6235-6243.
9. Metz B., Kersten G.F.A., Baart G.J.E., de Jong A., Meiring H., ten Hove J., et al. Identification of formaldehyde-induced modifications in proteins: reactions with insulin. Bioconjug Chem 2006, 17:815-822.
10. Shi S., Key M., Kalra K. Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991, 39:741-748.
11. Shi S.R., Shi Y., Taylor C.R. Antigen retrieval immunohistochemistry: review and future prospects in research and diagnosis over two decades. J Histochem Cytochem 2011, 59:13-32.
12. Tanca A., Pagnozzi D., Addis M.F. Setting proteins free: progresses and achievements in proteomics of formalin-fixed, paraffin-embedded tissues. Proteomics Clin Appl 2012, 6:7-21.
13. Prieto D.A., Hood B.L., Darfler M.M., Guiel T.G., Lucas D.A., Conrads T.P., et al. Liquid tissue: proteomic profiling of formalin-fixed tissues. Biotechniques 2005, (Suppl.):32-35.
14. Shi S.R., Liu C., Balgley B.M., Lee C., Taylor C.R. Protein extraction from formalin-fixed, paraffin-embedded tissue sections: quality evaluation by mass spectrometry. J Histochem Cytochem 2006, 54:739-743.
15. Becker K.F., Schott C., Hipp S., Metzger V., Porschewski P., Beck R., et al. Quantitative protein analysis from formalin-fixed tissues: implications for translational clinical research and nanoscale molecular diagnosis. J Pathol 2007, 211:370-378.
16. Nirmalan N.J., Harnden P., Selby P.J., Banks R.E. Development and validation of a novel protein extraction methodology for quantitation of protein expression in formalin-fixed paraffin-embedded tissues using western blotting. J Pathol 2009, 217:497-506.
17. Addis M.F., Tanca A., Pagnozzi D., Crobu S., Fanciulli G., Cossu-Rocca P., et al. Generation of high-quality protein extracts from formalin-fixed, paraffin-embedded tissues. Proteomics 2009, 9:3815-3823.
18. Ostasiewicz P., Zielinska D.F., Mann M., Wiśniewski J.R. Proteome, phosphoproteome, and N-glycoproteome are quantitatively preserved in formalin-fixed paraffin-embedded tissue and analyzable by high-resolution mass spectrometry. J Proteome Res 2010, 9:3688-3700.
19. Azimzadeh O., Barjaktarovic Z., Aubele M., Calzada-Wack J., Sarioglu H., Atkinson M.J., et al. Formalin-fixed paraffin-embedded (FFPE) proteome analysis using gel-free and gel-based proteomics. J Proteome Res 2010, 9:4710-4720.
20. Alkhas A., Hood B.L., Oliver K., Teng P.-n., Oliver J., Mitchell D., et al. Standardization of a sample preparation and analytical workflow for proteomics of archival endometrial cancer tissue. J Proteome Res 2011, 10:5264-5271.
21. Fowler C.B., Waybright T.J., Veenstra T.D., O'Leary T.J., Mason J.T. Pressure-assisted protein extraction: a novel method for recovering proteins from archival tissue for proteomic analysis. J Proteome Res 2012, 11:2602-2608.
22. Crockett D.K., Lin Z., Vaughn C.P., Lim M.S., Elenitoba-Johnson K.S.J. Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS. Lab Invest 2005, 85:1405-1415.
23. Palmer-Toy D.E., Krastins B., Sarracino D.A., Nadol J.B., Merchant S.N. Efficient method for the proteomic analysis of fixed and embedded tissues. J Proteome Res 2005, 4:2404-2411.
24. Hood B.L., Darfler M.M., Guiel T.G., Furusato B., Lucas D.A., Ringeisen B.R., et al. Proteomic analysis of formalin-fixed prostate cancer tissue. Mol Cell Proteomics 2005, 4:1741-1753.
25. Guo T., Wang W., Rudnick P.A., Song T., Li J., Zhuang Z., et al. Proteome analysis of microdissected formalin-fixed and paraffin-embedded tissue specimens. J Histochem Cytochem 2007, 55:763-772.
26. Jiang X., Jiang X., Feng S., Tian R., Ye M., Zou H. Development of efficient protein extraction methods for shotgun proteome analysis of formalin-fixed tissues. J Proteome Res 2007, 6:1038-1047.
27. Sprung R.W., Brock J.W.C., Tanksley J.P., Li M., Washington M.K., Slebos R.J.C., et al. Equivalence of protein inventories obtained from formalin-fixed paraffin-embedded and frozen tissue in multidimensional liquid chromatography-tandem mass spectrometry shotgun proteomic analysis. Mol Cell Proteomics 2009, 8:1988-1998.
28. Bell L.N., Saxena R., Mattar S.G., You J., Wang M., Chalasani N. Utility of formalin-fixed, paraffin-embedded liver biopsy specimens for global proteomic analysis in nonalcoholic steatohepatitis. Proteomics Clin Appl 2011, 5:397-404.
29. Gámez-Pozo A., Sánchez-Navarro I., Calvo E., Díaz E., Miguel-Martín M., López R., et al. Protein phosphorylation analysis in archival clinical cancer samples by shotgun and targeted proteomics approaches. Mol Biosyst 2011, 7:2368.
30. Patel V., Hood B.L., Molinolo A.A., Lee N.H., Conrads T.P., Braisted J.C., et al. Proteomic analysis of laser-captured paraffin-embedded tissues: a molecular portrait of head and neck cancer progression. Clin Cancer Res 2008, 14:1002-1014.
31. Perroud B., Ishimaru T., Borowsky A.D., Weiss R.H. Grade-dependent proteomics characterization of kidney cancer. Mol Cell Proteomics 2009, 8:971-985.
32. Huang S.K., Darfler M.M., Nicholl M.B., You J., Bemis K.G., Tegeler T.J., et al. LC/MS-based quantitative proteomic analysis of paraffin-embedded archival melanomas reveals potential proteomic biomarkers associated with metastasis. PLoS One 2009, 4:e4430.
33. Kawamura T., Nomura M., Tojo H., Fujii K., Hamasaki H., Mikami S., et al. Proteomic analysis of laser-microdissected paraffin-embedded tissues: (1) stage-related protein candidates upon non-metastatic lung adenocarcinoma. J Proteomics 2010, 73:1089-1099.
34. Xiao Z., Li G., Chen Y., Li M., Peng F., Li C., et al. Quantitative proteomic analysis of formalin-fixed and paraffin-embedded nasopharyngeal carcinoma using iTRAQ labeling, two-dimensional liquid chromatography, and tandem mass spectrometry. J Histochem Cytochem 2010, 58:517-527.
35. Bateman N.W., Sun M., Bhargava R., Hood B.L., Darfler M.M., Kovatich A.J., et al. Differential proteomic analysis of late-stage and recurrent breast cancer from formalin-fixed paraffin-embedded tissues. J Proteome Res 2011, 10:1323-1332.
36. Tanca A., Addis M.F., Pagnozzi D., Cossu-Rocca P., Tonelli R., Falchi G., et al. Proteomic analysis of formalin-fixed, paraffin-embedded lung neuroendocrine tumor samples from hospital archives. J Proteomics 2011, 74:359-370.
37. Wisniewski J.R., Ostasiewicz P., Mann M. High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. J Proteome Res 2011, 10:3040-3049.
38. Azimzadeh O., Scherthan H., Yentrapalli R., Barjaktarovic Z., Ueffing M., Conrad M., et al. Label-free protein profiling of formalin-fixed paraffin-embedded (FFPE) heart tissue reveals immediate mitochondrial impairment after ionising radiation. J Proteomics 2012, 75:2384-2395.
39. Scicchitano M.S., Dalmas D.A., Boyce R.W., Thomas H.C., Frazier K.S. Protein extraction of formalin-fixed, paraffin-embedded tissue enables robust proteomic profiles by mass spectrometry. J Histochem Cytochem 2009, 57:849-860.
40. Nirmalan N.J., Hughes C., Peng J., McKenna T., Langridge J., Cairns D.A., et al. Initial development and validation of a novel extraction method for quantitative mining of the formalin-fixed, paraffin-embedded tissue proteome for biomarker investigations. J Proteome Res 2011, 10:896-906.
41. Tanca A., Pagnozzi D., Falchi G., Biosa G., Rocca S., Foddai G., et al. Impact of fixation time on GeLC-MS/MS proteomic profiling of formalin-fixed, paraffin-embedded tissues. J Proteomics 2011, 74:1015-1021.
42. Schirle M. Profiling core proteomes of human cell lines by one-dimensional PAGE and liquid chromatography-tandem mass spectrometry. Mol Cell Proteomics 2003, 2:1297-1305.
43. Old W.M., Meyer-Arendt K., Aveline-Wolf L., Pierce K.G., Mendoza A., Sevinsky J.R., et al. Comparison of label-free methods for quantifying human proteins by shotgun proteomics. Mol Cell Proteomics 2005, 4:1487-1502.
44. Piersma S.R., Fiedler U., Span S., Lingnau A., Pham T.V., Hoffmann S., et al. Workflow comparison for label-free, quantitative secretome proteomics for cancer biomarker discovery: method evaluation, differential analysis, and verification in serum. J Proteome Res 2010, 9:1913-1922.
45. Collier T.S., Sarkar P., Franck W.L., Rao B.M., Dean R.A., Muddiman D.C. Direct comparison of stable isotope labeling by amino acids in cell culture and spectral counting for quantitative proteomics. Anal Chem 2010, 82:8696-8702.
46. Collier T.S., Randall S.M., Sarkar P., Rao B.M., Dean R.A., Muddiman D.C. Comparison of stable-isotope labeling with amino acids in cell culture and spectral counting for relative quantification of protein expression. Rapid Commun Mass Spectrom 2011, 25:2524-2532.
47. Klopfleisch R., Lenze D., Hummel M., Gruber A.D. Metastatic canine mammary carcinomas can be identified by a gene expression profile that partly overlaps with human breast cancer profiles. BMC Cancer 2010, 10:618.
48. Klose P., Weise C., Bondzio A., Multhaup G., Einspanier R., Gruber A.D., et al. Is there a malignant progression associated with a linear change in protein expression levels from normal canine mammary gland to metastatic mammary tumors?. J Proteome Res 2011, 10:4405-4415.
49. Mohammed S.I., Meloni G.B., Pinna Parpaglia M.L., Marras V., Burrai G.P., Meloni F., et al. Mammography and ultrasound imaging of preinvasive and invasive canine spontaneous mammary cancer and their similarities to human breast cancer. Cancer Prev Res (Phila) 2011, 4:1790-1798.
50. Pinho S.S., Carvalho S., Cabral J., Reis C.A., Gartner F. Canine tumors: a spontaneous animal model of human carcinogenesis. Transl Res 2012, 159:165-172.
51. Misdorp W., Else R., Hellmén E., Lipscomb T. Histological classification of mammary tumors of the dog and the cat. 2nd series 1999, Armed Forces Institute of Pathology and World Health Organization, Washington (DC).
52. Pisanu S., Ghisaura S., Pagnozzi D., Biosa G., Tanca A., Roggio T., et al. The sheep milk fat globule membrane proteome. J Proteomics 2011, 74:350-358.
53. Spivak M., Weston J., Bottou L., Kall L., Noble W.S. Improvements to the percolator algorithm for peptide identification from shotgun proteomics data sets. J Proteome Res 2009, 8:3737-3745.
54. Gasteiger E., Gattiker A., Hoogland C., Ivanyi I., Appel R.D., Bairoch A. ExPASy: the proteomics server for in-depth protein knowledge and analysis. Nucleic Acids Res 2003, 31:3784-3788.
55. Lundgren D.H., Hwang S.I., Wu L., Han D.K. Role of spectral counting in quantitative proteomics. Expert Rev Proteomics 2010, 7:39-53.
56. Dai L., Li C., Shedden K.A., Lee C.J., Quoc H., Simeone D.M., et al. Quantitative proteomic profiling studies of pancreatic cancer stem cells. J Proteome Res 2010, 9:3394-3402.
57. Zybailov B., Mosley A.L., Sardiu M.E., Coleman M.K., Florens L., Washburn M.P. Statistical analysis of membrane proteome expression changes in Saccharomyces cerevisiae. J Proteome Res 2006, 5:2339-2347.
58. Liu H., Sadygov R.G., Yates J.R. A model for random sampling and estimation of relative protein abundance in shotgun proteomics. Anal Chem 2004, 76:4193-4201.
59. Lemaire R., Desmons A., Tabet J.C., Day R., Salzet M., Fournier I. Direct analysis and MALDI imaging of formalin-fixed, paraffin-embedded tissue sections. J Proteome Res 2007, 6:1295-1305.
60. Fang Y., Robinson D.P., Foster L.J. Quantitative analysis of proteome coverage and recovery rates for upstream fractionation methods in proteomics. J Proteome Res 2010, 9:1902-1912.
61. Halvey P.J., Ferrone C.R., Liebler D.C. GeLC-MRM quantitation of mutant KRAS oncoprotein in complex biological samples. J Proteome Res 2012, 11:3908-3913.
62. Ong S.E., Mann M. Mass spectrometry-based proteomics turns quantitative. Nat Chem Biol 2005, 1:252-262.
63. Levin Y., Schwarz E., Wang L., Leweke F.M., Bahn S. Label-free LC-MS/MS quantitative proteomics for large-scale biomarker discovery in complex samples. J Sep Sci 2007, 30:2198-2203.
64. Pham T.V., Piersma S.R., Oudgenoeg G., Jimenez C.R. Label-free mass spectrometry-based proteomics for biomarker discovery and validation. Expert Rev Mol Diagn 2012, 12:343-359.
65. Neilson K.A., Ali N.A., Muralidharan S., Mirzaei M., Mariani M., Assadourian G., et al. Less label, more free: approaches in label-free quantitative mass spectrometry. Proteomics 2011, 11:535-553.
66. America A.H.P., Cordewener J.H.G. Comparative LC-MS: a landscape of peaks and valleys. Proteomics 2008, 8:731-749.
67. Griffin N.M., Yu J., Long F., Oh P., Shore S., Li Y., et al. Label-free, normalized quantification of complex mass spectrometry data for proteomic analysis. Nat Biotechnol 2009, 28:83-89.
68. Carpenter B., MacKay C., Alnabulsi A., MacKay M., Telfer C., Melvin W.T., et al. The roles of heterogeneous nuclear ribonucleoproteins in tumour development and progression. Biochim Biophys Acta 2006, 1765:85-100.
69. Kim M.Y., Hur J., Jeong S. Emerging roles of RNA and RNA-binding protein network in cancer cells. BMB Rep 2009, 42:125-130.
70. van Kouwenhove M., Kedde M., Agami R. MicroRNA regulation by RNA-binding proteins and its implications for cancer. Nat Rev Cancer 2011, 11:644-656.
71. Wurth L. Versatility of RNA-binding proteins in cancer. Comp Funct Genomics 2012, 2012:178525.
72. Silvera D., Formenti S.C., Schneider R.J. Translational control in cancer. Nat Rev Cancer 2010, 10:254-266.
73. Stumpf C.R., Ruggero D. The cancerous translation apparatus. Curr Opin Genet Dev 2011, 21:474-483.
74. Ralph S.J., Rodriguez-Enriquez S., Neuzil J., Saavedra E., Moreno-Sanchez R. The causes of cancer revisited: "mitochondrial malignancy" and ROS-induced oncogenic transformation - why mitochondria are targets for cancer therapy. Mol Aspects Med 2010, 31:145-170.
75. Gogvadze V. Targeting mitochondria in fighting cancer. Curr Pharm Des 2011, 17:4034-4046.
76. Hu H., Deng C., Yang T., Dong Q., Chen Y., Nice E.C., et al. Proteomics revisits the cancer metabolome. Expert Rev Proteomics 2011, 8:505-533.
77. Putignani L., Raffa S., Pescosolido R., Rizza T., Del Chierico F., Leone L., et al. Preliminary evidences on mitochondrial injury and impaired oxidative metabolism in breast cancer. Mitochondrion 2012, 12:363-369.
78. Pucci-Minafra I., Albanese N.N., Di Cara G., Minafra L., Marabeti M.R., Cancemi P. Breast cancer cells exhibit selective modulation induced by different collagen substrates. Connect Tissue Res 2008, 49:252-256.
79. Keely P.J. Mechanisms by which the extracellular matrix and integrin signaling act to regulate the switch between tumor suppression and tumor promotion. J Mammary Gland Biol Neoplasia 2011, 16:205-219.
80. Taylor M.A., Lee Y.H., Schiemann W.P. Role of TGF-beta and the tumor microenvironment during mammary tumorigenesis. Gene Expr 2011, 15:117-132.
81. Chow A., Arteaga C.L., Wang S.E. When tumor suppressor TGFbeta meets the HER2 (ERBB2) oncogene. J Mammary Gland Biol Neoplasia 2011, 16:81-88.
82. Zu X., Zhang Q., Cao R., Liu J., Zhong J., Wen G., et al. Transforming growth factor-beta signaling in tumor initiation, progression and therapy in breast cancer: an update. Cell Tissue Res 2012, 347:73-84.
83. Chen Y., Olopade O.I. MYC in breast tumor progression. Expert Rev Anticancer Ther 2008, 8:1689-1698.
84. Hynes N.E., Stoelzle T. Key signalling nodes in mammary gland development and cancer: Myc. Breast Cancer Res 2009, 11:210.
85. Ma L., Young J., Prabhala H., Pan E., Mestdagh P., Muth D., et al. miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 2010, 12:247-256.
86. Lin S.C., Chou Y.C., Wu M.H., Wu C.C., Lin W.Y., Yu C.P., et al. Genetic variants of myeloperoxidase and catechol-O-methyltransferase and breast cancer risk. Eur J Cancer Prev 2005, 14:257-261.
87. Mojtahedi Z., Safaei A., Yousefi Z., Ghaderi A. Immunoproteomics of HER2-positive and HER2-negative breast cancer patients with positive lymph nodes. OMICS 2011, 15:409-418.
88. He J., Whelan S.A., Lu M., Shen D., Chung D.U., Saxton R.E., et al. Proteomic-based biosignatures in breast cancer classification and prediction of therapeutic response. Int J Proteomics 2011, 2011:896476.
89. Correa C.R., Bertollo C.M., Zouain C.S., Goes A.M. Glyceraldehyde-3-phosphate dehydrogenase as a surface associated antigen on human breast cancer cell lines MACL-1 and MGSO-3. Oncol Rep 2010, 24:677-685.
90. Isidoro A., Casado E., Redondo A., Acebo P., Espinosa E., Alonso A.M., et al. Breast carcinomas fulfill the Warburg hypothesis and provide metabolic markers of cancer prognosis. Carcinogenesis 2005, 26:2095-2104.
91. Huang T.C., Chang H.Y., Hsu C.H., Kuo W.H., Chang K.J., Juan H.F. Targeting therapy for breast carcinoma by ATP synthase inhibitor aurovertin B. J Proteome Res 2008, 7:1433-1444.
92. Pan J., Sun L.-C., Tao Y.-F., Zhou Z., Du X.-L., Peng L., et al. ATP synthase ecto-alpha-subunit: a novel therapeutic target for breast cancer. J Transl Med 2011, 9:211.
93. Nicotra G., Castino R., Follo C., Peracchio C., Valente G., Isidoro C. The dilemma: does tissue expression of cathepsin D reflect tumor malignancy? The question: does the assay truly mirror cathepsin D mis-function in the tumor?. Cancer Biomark 2010, 7:47-64.
94. Guttery D.S., Hancox R.A., Mulligan K.T., Hughes S., Lambe S.M., Pringle J.H., et al. Association of invasion-promoting tenascin-C additional domains with breast cancers in young women. Breast Cancer Res 2010, 12:R57.
95. Guttery D.S., Shaw J.A., Lloyd K., Pringle J.H., Walker R.A. Expression of tenascin-C and its isoforms in the breast. Cancer Metastasis Rev 2010, 29:595-606.
96. Oskarsson T., Acharyya S., Zhang X.H., Vanharanta S., Tavazoie S.F., Morris P.G., et al. Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs. Nat Med 2011, 17:867-874.
97. Dong D., Ni M., Li J., Xiong S., Ye W., Virrey J.J., et al. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Cancer Res 2008, 68:498-505.
98. Croci S., Recktenwald C.V., Lichtenfels R., Nicoletti G., Dressler S.P., De Giovanni C., et al. Proteomic and PROTEOMEX profiling of mammary cancer progression in a HER-2/neu oncogene-driven animal model system. Proteomics 2010, 10:3835-3853.
99. Sarrio D., Rodriguez-Pinilla S.M., Dotor A., Calero F., Hardisson D., Palacios J. Abnormal ezrin localization is associated with clinicopathological features in invasive breast carcinomas. Breast Cancer Res Treat 2006, 98:71-79.
100. Chang X.Z., Li D.Q., Hou Y.F., Wu J., Lu J.S., Di G.H., et al. Identification of the functional role of peroxiredoxin 6 in the progression of breast cancer. Breast Cancer Res 2007, 9:R76.
101. de Graauw M., van Miltenburg M.H., Schmidt M.K., Pont C., Lalai R., Kartopawiro J., et al. Annexin A1 regulates TGF-beta signaling and promotes metastasis formation of basal-like breast cancer cells. Proc Natl Acad Sci U S A 2010, 107:6340-6345.
102. Calderwood S.K. Heat shock proteins in breast cancer progression-a suitable case for treatment?. Int J Hyperthermia 2010, 26:681-685.
103. de Oliveira J.T., de Matos A.J., Gomes J., Vilanova M., Hespanhol V., Manninen A., et al. Coordinated expression of galectin-3 and galectin-3-binding sites in malignant mammary tumors: implications for tumor metastasis. Glycobiology 2010, 20:1341-1352.
104. Chu P.Y., Hsu N.C., Liao A.T., Shih N.Y., Hou M.F., Liu C.H. Overexpression of alpha-enolase correlates with poor survival in canine mammary carcinoma. BMC Vet Res 2011, 7:62.
105. Jang J.Y., Choi Y., Jeon Y.K., Kim C.W. Suppression of adenine nucleotide translocase-2 by vector-based siRNA in human breast cancer cells induces apoptosis and inhibits tumor growth in vitro and in vivo. Breast Cancer Res 2008, 10:R11.
106. Wadhwa R., Takano S., Kaur K., Deocaris C.C., Pereira-Smith O.M., Reddel R.R., et al. Upregulation of mortalin/mthsp70/Grp75 contributes to human carcinogenesis. Int J Cancer 2006, 118:2973-2980.
107. Martin B., Sanz R., Aragues R., Oliva B., Sierra A. Functional clustering of metastasis proteins describes plastic adaptation resources of breast-cancer cells to new microenvironments. J Proteome Res 2008, 7:3242-3253.
108. Desmetz C., Bibeau F., Boissiere F., Bellet V., Rouanet P., Maudelonde T., et al. Proteomics-based identification of HSP60 as a tumor-associated antigen in early stage breast cancer and ductal carcinoma in situ. J Proteome Res 2008, 7:3830-3837.
109. Blow N. Tissue preparation: tissue issues. Nature 2007, 448:959-963.
110. Espina V., Mueller C., Edmiston K., Sciro M., Petricoin E.F., Liotta L.A. Tissue is alive: new technologies are needed to address the problems of protein biomarker pre-analytical variability. Proteomics Clin Appl 2009, 3:874-882.
111. Espina V., Mueller C. Reduction of preanalytical variability in specimen procurement for molecular profiling. Methods Mol Biol 2012, 823:49-57.
112. Nirmalan N.J., Harnden P., Selby P.J., Banks R.E. Mining the archival formalin-fixed paraffin-embedded tissue proteome: opportunities and challenges. Mol Biosyst 2008, 4:712.
113. Wolff C., Schott C., Porschewski P., Reischauer B., Becker K.F. Successful protein extraction from over-fixed and long-term stored formalin-fixed tissues. PLoS One 2011, 6:e16353.
114. Tabb D.L., Vega-Montoto L., Rudnick P.A., Variyath A.M., Ham A.J., Bunk D.M., et al. Repeatability and reproducibility in proteomic identifications by liquid chromatography-tandem mass spectrometry. J Proteome Res 2010, 9:761-776.
115. Tanca A., Pagnozzi D., Falchi G., Tonelli R., Rocca S., Roggio T., et al. Application of 2-D DIGE to formalin-fixed, paraffin-embedded tissues. Proteomics 2011, 11:1005-1011.
116. Addis M.F., Tanca A., Pagnozzi D., Rocca S., Uzzau S. 2-D PAGE and MS analysis of proteins from formalin-fixed, paraffin-embedded tissues. Proteomics 2009, 9:4329-4339.
117. Tanca A., Addis M.F., Simula M.P., Pagnozzi D., Biosa G., Pisanu S., et al. Evaluation of the suitability of archival Bouin-fixed paraffin-embedded tissue specimens to proteomic investigation. Electrophoresis 2012, 33:1375-1384.